羊膜市場の市場規模、シェア、成長分析：製品別、用途別、最終用途別、地域別 - 産業予測 2025～2032年

羊膜市場規模は、2023年に45億米ドルと評価され、2024年の51億8,000万米ドルから2032年には159億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは15.1％で成長する見通しです。

羊膜（AM）は、胚を取り囲む重要な構造であり、眼科および整形外科疾患の有病率の上昇により、医療分野で支持を集めています。外科的処置におけるAMの利点により、患者の回復時間を向上させるため、AMを選択する医師が増えています。このような需要の高まりは、外科手術の効率を最適化する革新的なAM製品を開発するメーカーに十分な機会を与えています。さらに、美容外科手術の増加は、市場の成長をさらに刺激する可能性が高いです。凍結保存、生物工学、組織工学における最近の進歩により、羊水由来の生体適合性足場や改良型製剤が生み出されています。これらの技術革新は組織の修復、再生、再生調節を強化し、予測期間中の羊膜市場の可能性を強めています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

羊膜市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 冷凍保存された羊膜
• 脱水性羊膜

羊膜市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 手術創
• 眼科
• その他

羊膜市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 病院
• 外来手術センター
• 専門クリニック
• 調査機関および学術機関

羊膜市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• MiMedx Group, Inc.（USA）
• Integra LifeSciences Holdings Corporation.（USA）
• Organogenesis Holdings Inc.（USA）
• Smith & Nephew plc.（UK）
• BioTissue Holdings Inc.（USA）
• Amnio Technology, LLC.（USA）
• Applied Biologics LLC.（USA）
• Celularity Inc.（USA）
• Corza Health, Inc.（USA）
• Skye Biologics, Inc.（USA）
• Human Regenerative Technologies, LLC.（USA）
• Katena Products Inc.（USA）
• TissueTech Inc.（BioTissue）（USA）
• Amniox Medical Inc.（USA）
• Laboratoire CCD.（France）
• VIVEX Biologics Inc.（USA）
• Merakris Therapeutics.（USA）
• Thea Pharma.（France）
• Allosure, Inc.（USA）
• Xtant Medical Holdings Inc.（USA）

結論と提言

Amniotic Membrane Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 5.18 billion in 2024 to USD 15.95 billion by 2032, growing at a CAGR of 15.1% during the forecast period (2025-2032).

The amniotic membrane (AM), a vital structure surrounding the embryo, is gaining traction in the medical field due to the rising prevalence of ophthalmic and orthopedic conditions. Physicians are increasingly opting for AM due to its benefits in surgical procedures, which enhances recovery times for patients. This growing demand presents ample opportunities for manufacturers to develop innovative AM products that optimize surgical efficiency. Additionally, the rise in aesthetic surgical procedures is likely to further stimulate market growth. Recent advancements in cryopreservation, bioengineering, and tissue engineering have led to the creation of biocompatible scaffolds and improved formulations derived from amniotic fluid. These innovations enhance tissue repair, regeneration, and regenerative modulation, reinforcing the amniotic membrane market's potential during the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Amniotic Membrane market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Amniotic Membrane Market Segments Analysis

Global Amniotic Membrane Market is segmented by Product, Application, End Use and region. Based on Product, the market is segmented into Cryopreserved Amniotic Membrane and Dehydrated Amniotic Membrane. Based on Application, the market is segmented into Surgical Wounds, Ophthalmology and Others. Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Research Institutes and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Amniotic Membrane Market

The rising incidence of severe injuries among workers engaged in field activities is driving the demand for prompt and efficient healing solutions. In particular, road accidents are a leading cause of traumatic injuries in children and young adults. With road safety measures being compromised and traffic congestion intensifying globally, accident rates are surging. This increase in both the number of accidents and resultant trauma directly contributes to the growth of the amniotic membrane market, as it highlights the urgent need for advanced therapeutic options to facilitate faster recovery and healing processes for affected individuals.

Restraints in the Amniotic Membrane Market

The amniotic membrane market faces significant restraints primarily due to the high costs associated with amniotic products and their related services. These products require specialized biological processing and manufacturing techniques to preserve their natural properties and ensure safety. The necessity for rigorous quality control, extensive testing, and adherence to regulatory standards complicates these processes, further escalating production expenses. As a result, patients, suppliers, and healthcare systems may find it challenging to access or afford these advanced treatments, potentially hindering market growth and limiting overall patient care options within the sector.

Market Trends of the Amniotic Membrane Market

The amniotic membrane market is witnessing significant growth driven by improving healthcare policies in emerging economies such as China, India, South Korea, Brazil, and Mexico. These nations present lucrative opportunities due to reduced regulatory hurdles, enhanced healthcare infrastructure, and a rapidly increasing patient population. Rising healthcare expenditures further bolster market expansion, while more flexible governance models promote pro-business environments compared to developed markets. Consequently, established players are increasingly targeting these regions to capitalize on their competitive advantages, fueling a robust demand for amniotic membrane products in regenerative medicine and surgical applications, thus shaping a dynamic landscape in the global market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Amniotic Membrane Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cryopreserved Amniotic Membrane
• Dehydrated Amniotic Membrane

Global Amniotic Membrane Market Size by Application & CAGR (2025-2032)

• Market Overview
• Surgical Wounds
• Ophthalmology
• Others

Global Amniotic Membrane Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research Institutes and Academic Institutes

Global Amniotic Membrane Market Size & CAGR (2025-2032)

• North America (Product, Application, End Use)
  • US
  • Canada
• Europe (Product, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• MiMedx Group, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organogenesis Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTissue Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amnio Technology, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied Biologics LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celularity Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corza Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Skye Biologics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Human Regenerative Technologies, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Katena Products Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TissueTech Inc. (BioTissue) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amniox Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratoire CCD. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VIVEX Biologics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merakris Therapeutics. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thea Pharma. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allosure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xtant Medical Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations